/Johnson%20%26%20Johnson%20corporate%20building%20By%20PixelBiss.jpeg){kind=tracking}
New Brunswick, New Jersey-based Johnson & Johnson (JNJ), researches, develops, manufactures, and sells healthcare products across the innovative medicine and medtech sectors. With a market cap of $655.4 billion, the company offers prescription pharmaceuticals, diagnostic equipment, surgical instruments, and medical devices. The healthcare giant is expected to announce its fiscal third-quarter earnings for 2026 before the market opens on Tuesday, Oct. 13.
Ahead of the event, analysts expect Johnson & Johnson to report a profit of $2.96 per share on a diluted basis, up 5.7% from $2.80 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.
